Introduction
Robin Smith
MD MBA
Dr. Smith is Chairman of the Board of Directors and Chief Executive Officer of NeoStem, Inc., (AMEX:NBS) an adult stem cell collection processing and long term storage company. She is also a managing director of the Madelin Fund. Prior to this position, Dr. Smith has acted as a senior advisor and investor to both publicly traded where she has played a significant role in restructuring and or growing the companies. Additionally, she assisted multiple investment banks where she evaluated companies in healthcare, media and emerging technologies. Dr. Smith also serves on the Board of Trustees of the NYU Medical Center Board and is Chairman of the Board of Directors for the New York University Hospital for Joint Diseases where she heads up new development efforts and board member recruitment. She also served on the Chemotherapy Foundation Board of Trustees, The New York Theatre Ballet board and Choose Living board of Directors as well as Talon Air.